Mesenchymal Stem Cells in Clinical Applications
Author:
- 19 October 2016
- book chapter
- Published by Springer Nature
- p. 37-69
Abstract
No abstract availableKeywords
This publication has 176 references indexed in Scilit:
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyThe Lancet Neurology, 2012
- Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37Stem Cells, 2010
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJACC, 2009
- Mesenchymal stem cells suppress B-cell terminal differentiationExperimental Hematology, 2009
- Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and HumansStem Cells, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditionsCytotechnology, 2008
- Autologous umbilical cord blood infusion for type 1 diabetesExperimental Hematology, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- Surface protein characterization of human adipose tissue‐derived stromal cellsJournal of Cellular Physiology, 2001